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A New Prognostic Marker or Mainly a Correlate
of Lung Allograft Function?*Francois Haddad, MD,y Elie Fadel, MD, PHDzI n recent years, more attention has been given toright ventricular (RV) function in cardiovascularand pulmonary disease (1,2). Ghio et al. (3) were
the ﬁrst to clearly demonstrate that the presence of
RV systolic dysfunction and pulmonary hyperten-
sion (PH) increases the likelihood of a poor outcome
in patients with heart failure with reduced ejection
fraction. More recently, among 406 patients with
PH, Fine et al. (4) showed that RV global longitudi-
nal strain (GLS) is a strong and independent prog-
nostic marker of event-free survival along with
functional class and N-terminal B-type natriuretic
peptide levels. The study of Kusunose et al. (5), in
this issue of iJACC, builds on these previous studies
but with an original focus on post–lung transplanta-
tion outcome. Consistent with the ﬁndings of Ghio
et al. (3) and Fine et al. (4), the authors highlight
the potential prognostic importance of post–lung
transplantation RVGLS and PH.SEE PAGE 1084In recent years, there has been a great interest in
using myocardial strain as a metric of ventricular
function. This stems from the observation that RV
longitudinal strain may represent an earlier marker of
ventricular dysfunction compared with ejection
fraction or annular displacement. In addition, RV
strain measures could be more reproducible than
right ventricular fractional area change (RVFAC).*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
the authors and do not necessarily represent the views of JACC:
Cardiovascular Imaging or the American College of Cardiology.
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and Cardiovascular Institute, Stanford University, Palo Alto, California;
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Marie-Lannelongue, Université Paris-Sud, Orsay, France. Both authors
have reported that they have no relationships relevant to the contents
of this paper to disclose.Conceptually, strain refers to an object’s fractional or
percent of change from its original unstressed
dimension (i.e., a change in length corrected for the
original length or [L1  L0]/L0, where L0 is the orig-
inal length and L1 the length after deformation).
Strain can be calculated in several dimensions; lon-
gitudinal, circumferential, or radial and a more
negative value of strain corresponds to better ven-
tricular function. Using 2-dimensional echocardiog-
raphy, RV strain is usually only measured in the
longitudinal dimension as the right ventricle is not
often completely visualized in the short-axis planes.
RV longitudinal stain is higher than LV strain and
“normal” values are reported to be lower than 25%
(RV free wall excluding the septal component) (4).
Current studies are ongoing to determine the most
accurate, reproducible, and time-efﬁcient method to
measure RVGLS. At the present time, different
methods of RV strain have been described including
manual tracing, tissue Doppler imaging, speckle
tracking, and, as recently described, a 3-dimensional
method (6–8). Compared with tissue Doppler, speckle
imaging has the advantage of being less inﬂuenced by
the insonation angle or ventricular wall motion, as is
currently the most frequently used method.
In their study, Kusunose et al. (5) describe the
extent of RV and left ventricular remodeling after
lung transplantation for advanced lung disease (9).
Among functional indexes, the improvements were
more notable for RVFAC and RVGLS. In contrast,
tricuspid annular plane systolic excursion (TAPSE)
did not show signiﬁcant change after lung trans-
plantation, a ﬁnding highlighting the less sensitive
nature of TAPSE for global changes in ventricular
function. Among factors potentially inﬂuencing the
remodeling process, the authors observed that
patients with pulmonary ﬁbrosis and higher base-
line pulmonary pressure had a greater degree of
remodeling and functional improvement. The more
signiﬁcant change in patients with pulmonary ﬁbrosis
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1096may be in part secondary to the fact that they had
higher baseline pulmonary vascular resistance and
lower baseline RVGLS.
As highlighted by several studies, the right
ventricle has a remarkable ability to reverse remodel
and improve its function after a decrease in RV
afterload (1,2,10). Frist et al. (9) were one of the ﬁrst
groups to demonstrate that, in patients with pulmo-
nary arterial hypertension undergoing lung trans-
plantation, the right heart reverse remodels almost to
normal by 1 year post-transplantation. The study of
Frist et al. (9) also points to the importance of stan-
dardizing the time of RV assessment because the
remodeling process may take up to 1 year. This may
be less important in advanced lung disease as in the
study of Kusunose et al. (5) because the extent of RV
dysfunction at baseline is less severe, and remodeling
may occur earlier. Pathophysiologically, the greater
capacity of the right ventricle to reverse remodel
compared with the pressure-overloaded left ventricle
may be in part explained by the smaller extent of
ﬁbrosis observed (11–14).
The other major ﬁnding of the study was the fact
that patients with both RV dysfunction and PH after
lung transplantation had signiﬁcantly worst out-
comes. As the authors acknowledge, however, the
retrospective nature of the study, the potential of
selection biases, the variable timing of the echocar-
diographic evaluation, and the absence of a valida-
tion cohort make the interpretation of the outcome
analysis more challenging. For example, only pa-
tients who had a follow-up echocardiogram were
included in the study; these patients may have signs
of heart failure or lung allograft dysfunction at time
of evaluation. Also, the variable timing of post-
transplantation echocardiographic evaluation may
introduce a time bias because the remodeling pro-
cess may not be at the same stage in each patient.The authors did, however, attempt to adjust for this
by adding follow-up time in the survival analysis.
Finally and more importantly, we wonder whether
RV function and PH are “truly” independent prog-
nostic markers of event-free survival after lung
transplantation or mainly markers of worse lung
allograft function. In fact, the missing covariate in
the multivariable model is the presence of bron-
chiolitis obliterans syndrome or pulmonary function
test results (15). Bronchiolitis obliterans already
represents a very strong prognostic marker in lung
transplantation but usually occurs later in the post-
transplantation course (15). Notwithstanding these
limitations, the study does point to very important
observations with regard to RV function and
outcome after lung transplantation. In fact, as the
authors highlight, pre-transplantation RV function
does not appear to be associated with post-
transplantation outcome. Also consistent with the
study Fine et al. (4), the ﬁndings suggest that RVGLS
could carry more prognostic information than RVFAC
or TAPSE. Interestingly, the ﬁndings of the study are
strongly reminiscent of the Kaplan-Meier survival
curve of the study of Ghio et al. (3).
This study not only brings novel insights to RV
function after lung transplantation but also guides
future studies on the topic. Whether RV function
brings incremental prognostic information to the
presence of bronchiolitis obliterans and whether an
intervention can improve outcomes in these higher
risk individuals will require further study.
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